Alchemy 21/12 Opens to the Public With a Barrier-First Skincare System

By Regina Bonham Bordeaux

Alchemy 21/12 has opened to the public after three years of private use, introducing a skincare and scalp-care collection built around a barrier-first routine the brand calls The Alchemy Method.^[1]

The interesting part is not simply the use of PDRN, peptides, copper peptides, and extracellular vesicles. It is the way the brand sequences them: hydrate and calm first, then add more intensive treatment steps.

What launched

The public lineup includes Barrier Cleanser, Recover-Me EGCG + PAD Toner, Enzyme + PHA Resurfacing Polish, Crystal PDRN Glass Serum, Recover-Me 3S CORRECTV Complex, Recover-Me Barrier Cream, GHK Night Cream, and AHK Peptide Hair & Scalp Serum.^[1]

Alchemy 21/12 organizes the routine around four stages: Hydrate, Calm, Strengthen, and Signal. Products featuring ingredients such as PDRN, peptides, extracellular vesicles, and copper peptides appear later in the routine rather than at the beginning.^[1][2]

Current individual product prices on the brand’s U.S. site range from $38 for the Barrier Cleanser to $148 for the GHK Night Cream. The company also offers curated routines and a $36 five-product Discovery Sample Set.^[3]

Why it matters

Barrier support is already a basic part of a well-designed skincare routine, especially when stronger treatments are involved. Alchemy 21/12 turns that familiar principle into the organizing idea for the entire line.

For shoppers, the real question is whether the system offers a meaningful advantage over a simpler routine that already prioritizes hydration, barrier support, and careful use of active products. The ingredient names alone do not answer that.

What we know

Alchemy 21/12 says founder Jen Valenti began developing the formulas after experiencing skin changes during perimenopause and worsening rosacea. The products were then used within a private group before the public launch, with that feedback helping shape the collection.^[1]

The brand also presents ingredient-level and ex vivo data for selected materials used across the line. That can help explain why an ingredient was chosen, but it does not establish how a finished Alchemy 21/12 product—or the complete routine—performs on human skin.

The company describes the collection as vegan, fragrance-free, cruelty-free, retinoid-free, formulated in Los Angeles, and made in the United States.^[1]

What we’re watching

BB will be watching for finished-product clinical testing, including participant numbers, study design, measured outcomes, and enough detail to judge whether the products themselves deliver more than the ingredient story suggests.

We are also watching whether “barrier-first biotech” becomes a genuinely distinct skincare category or simply a new way to package a familiar principle: support the barrier first, then add stronger treatment steps carefully.